Purchase this article with an account.
O. Alvarez-Verduzco, M. Torres-Soriano, E. Reyna-Castelan, M. Hernandez-Rojas, J. L. Díaz-Rubio, G. García-Aguirre, J. L. Guerrero-Naranjo, J. M. Jiménez-Sierra, H. Quiroz-Mercado; Tractional Retinal Detachment After Intravitreal Injection of Bevacizumab in Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2007;48(13):1412. doi: https://doi.org/.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To asses the incidence of tractional retinal detachment (TRD) induced by a single dose of intravitreal bevacizumab in patients with proliferative diabetic retinopathy (PDR).
Retrospective review of 343 patients with PDR who where treated with intravitreal injection of bevacizumab (2.5mg/0.1ml).
Five patients (1.45%) presented tractional retinal detachment 1 to 6 weeks (mean 3 weeks) after intravitreal injection. All cases underwent pars plana vitrectomy, removal of all epiretinal fibrovascular membranes, further endolaser panretinal photocoagulation and silicone tamponade.
Tractional retinal detachment may occur in a short time post intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy with extense areas of ischemia and fibrovascular proliferations, and may require prompt vitreoretinal surgery.
This PDF is available to Subscribers Only